Cardiac Stem-Cell Pioneer Capricor Closes Financing

Los Angeles-based Capricor, Inc. announced its most recent capital infusion of nearly $2 million from Broadview Ventures and private individual investors. The funds will be used toward the development of U.S. clinical trials for cardiac therapies based on Capricor's proprietary mix of stem cells derived from adult (non-embryonic) cardiac tissue, which regenerate damaged areas of the heart and improve heart function.apricor's team of world-renowned cardiac stem cell researchers and advisory board members, including founder Eduardo Marbán, M.D., Ph.D., are recognized for their notable scientific accomplishments. The team conducted pre-clinical research at Johns Hopkins School of Medicine and the University of Rome, demonstrating the effectiveness of Capricor's experimental biological stem cell heart therapy in animal models.

Currently, Capricor has a research partnership in Los Angeles with Cedars-Sinai Medical Center.  “Defying conventions, our team is creating bold, new approaches to stem cell therapy for the heart,” said Capricor co-founder and CEO Linda Marbán, Ph.D.  “Our proprietary cardiac stem cell mixture is an example of an ingenious and elegant avenue to leverage pre-destined heart cells for improved regeneration.” 

Martin Landaluce, Financial Director of Fondation Leducq and Fondation Leducq representative to Broadview Ventures, added, “In our view, Capricor’s investment appeal lies in its strong and growing IP portfolio that can lead to a robust pipeline of cardiac stem cell therapies.” 

Knobbe Martens has been representing Capricor since 2007, with Orange County partner Salima Merani, Ph.D., and associate Jason Gersting, Ph.D., managing Capricor's intellectual property portfolio.

For more information on Capricor please visit

With over 275 lawyers and scientists nationwide, Knobbe Martens Olson & Bear LLP dedicates its practice to all aspects of intellectual property law including litigation. Knobbe Martens serves a diverse group of clients from multinational corporations to emerging businesses of all stages. The firm is headquartered in Orange County, California with offices in San Diego, Los Angeles, Riverside, San Francisco, Seattle, and Washington, D.C., and enjoys an international reputation for excellence. More information about the firm can be found at

Contact: Jan Heying Emily Elkind 619-293-3175